Want to join the conversation?
Chemical company $DD reported a rise in 2Q16 earnings driven by lower costs and expenses as well as higher operating margins across all segments. Net income rose to $1.02Bil or $1.16 per share from $945MM or $1.03 per share last year. Net sales declined to $7.06Bil from $7.12Bil. Non-GAAP EPS grew to $1.24 from $1.09.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?